Treatment of Aspirin Resistance with Radix Salviae Miltiorrhizae, its extract and composition.

Details for Australian Patent Application No. 2004290484 (hide)

Owner Tianjin Tasly Pharmaceutical Co., Ltd.

Inventors Yan, Xijun; Guo, Zhixin; Zhang, Lei; Ye, Zhengliang; Zheng, Jun; Zhao, Na; Li, Xu; Wu, Naifeng

Agent Spruson & Ferguson

Pub. Number AU-B-2004290484

PCT Pub. Number WO2005/049058

Priority 200410019838.1 30.06.04 CN; 03155275.7 28.08.03 CN

Filing date 26 August 2004

Wipo publication date 2 June 2005

Acceptance publication date 25 March 2010

International Classifications

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 36/185 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines - Magnoliopsida (dicotyledons)

A61K 36/258 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 36/537 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/049058 Priority application(s): WO2005/049058

19 November 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Treatment of Aspirin Resistance with Radix Salviae Miltiorrhizae, its extract and composition.

25 March 2010 Application Accepted

  Published as AU-B-2004290484

13 May 2010 Corrigenda

  Applications Accepted - Name Index Under the name Tianjin Tasly Pharmaceutical Co., Ltd., Application No. 2004290484, under INID (72) delete coinventors Zhang, Lei and Zheng, Jun

22 July 2010 Standard Patent Sealed

2 August 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee name from Tianjin Tasly Pharmaceutical Co., Ltd. to Tasly Pharmaceutical Group Co., Ltd. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290493-Light protecting composition with reduced total amount of UV filter containing a polysiloxane-based UV filter

2004290476-Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents